Surgical treatment of Ebstein anomaly in pediatric patients: A 10-year single-center study.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 11 03 2021
accepted: 03 05 2021
pubmed: 1 6 2021
medline: 12 8 2021
entrez: 31 5 2021
Statut: ppublish

Résumé

We report the early and long-term results of the strategies and surgical methods used in our center to treat pediatric patients who underwent surgical intervention to correct Ebstein anomaly (EA) in our center. In our study, a consecutive sample of 29 patients who underwent surgery for EA between February 2011 and February 2020 in our center were evaluated retrospectively. The 29 patients underwent a total of 40 operations. Univentricular repair was performed in 5 (17.2%), 1.5 ventricular repair in 5 (17.2%), and biventricular repair in the remaining 19 (65.5%) patients. Cone reconstruction (CR) was performed in eight (27.5%), non-Cone tricuspid valve (TV) repair technique in five (17.2%), ring annuloplasty in two (6.9%), and TV replacement in two patients (6.9%) who had undergone biventricular repair. In two patients (6.9%), only close an atrial septal defect. Two (6.9%) patients underwent a second operation for advanced tricuspid regurgitation (TR) in the early period. None of the 15 patients who underwent CR and TV plasty had moderate or advanced TR before discharge. Early mortality was seen in 1 (3.4%) patient. The mean follow-up period of the patients was 48.4±27.6 months. Three (10.7%) of the patients who were discharged after their first operation later underwent a second operation for TV regurgitation in the long term. No mortality was observed in any patient during long-term follow-up. Surgical treatment of EA is difficult, but its overall results are good. The anatomical repair rate is lower in neonatal and infant patients requiring surgery, but most of these patients underwent biventricular repair. Our long-term results demonstrated an acceptable survival rate, low mortality in the early postoperative period, and low incidence of re-intervention and morbidity.

Identifiants

pubmed: 34056748
doi: 10.1111/jocs.15676
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3138-3145

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Belli E, Rabot M, Petit J, Gouton M. Ebstein's anomaly in adults: modified cone reconstruction of the tricuspid valve is associated with promising outcomes. Arch Cardiovasc Dis. 2017;110:325-33.
Dearani JA, Mora BN, Nelson TJ, Haile DT, O'Leary PW. Ebstein anomaly review: what's now, what's next? Expert Rev Cardiovasc Ther. 2015;13:1101-1109.
Hunter SW, Lillehei CW. Ebstein malformation of the tricuspid valve. Study of a case together with suggestions of a new form of surgical therapy. Dis Chest. 1958;33(3):297-304.
Hunter SW, Lillehei W. Ebstein's malformation of the tricuspid valve: Study of a case together with suggestion of a new form of surgical therapy. Dis Chest. 1958;33:297-304.
Danielson GK, Maloney JD, Devloo RA. Surgical repair of Ebstein's anomaly. Mayo Clin Proc. 1979;54:185-192.
Carpentier A, Chauvaud S, Macé L, et al. A new reconstructive operation for Ebstein's anomaly of the tricuspid valve. J Thorac Cardiovasc Surg. 1988;96:92-101.
da Silva JP, Baumgratz JF, da Fonseca L, et al. The cone reconstruction of the tricuspid valve in Ebstein's anomaly. The operation: early and midterm results. J Thorac Cardiovasc Surg. 2007;133:215-223.
Burri M, Lange R Surgical treatment of Ebstein's anomaly. Thorac Cardiovasc Surg. 2017;65:639-648.
Pasquali SK, Shahian DM, O'Brien SM, et al. Development of a congenital heart surgery composite quality metric: Part 1 conceptual framework. Ann Thorac Surg. 2019;107(2):583-589.
Geerdink LM, du Marchie Sarvaas, GJ, Kuipers, IM, et al. Surgical outcome in pediatric patients with Ebstein's anomaly: a multicenter, long-term study. Congenit Heart Dis. 2017;12(1):32-39.
Knott-Craig CJ, Goldberg SP, Ballweg JA, Boston US. Surgical decision making in neonatal Ebstein's anomaly: an algorithmic approach based on 48 consecutive neonates. World J Pediatr Congenit Heart Surg. 2012;3(1):16-20.
Reemtsen BL, Fagan BT, Wells WJ, Starnes VA. Current surgical therapy for Ebstein anomaly in neonates. J Thorac Cardiovasc Surg. 2006;132(6):1285-1290.
da Silva JP, Baumgratz JF, Fonseca L, et al. Ebstein's anomaly: results of the conical reconstruction of the tricuspid valve. Arq Bras Cardiol. 2004;82(3):217-220.
Silva JP, Silva Lda F, Moreira LF, et al. Cone reconstruction in Ebstein's anomaly repair: early and long-term results. Arq Bras Cardiol. 2011;97(3):199-208.
Holst KA, Dearani JA, Said S, et al. Improving results of surgery for Ebstein anomaly: where are we after 235 cone repairs? Ann Thorac Surg. 2018;105(1):160-168.
Dearani JA, Said SM, O'leary PW, Burkhart HM, Barnes RD, Cetta F. Anatomic repair of Ebstein's malformation: lessons learned with cone reconstruction. Ann Thorac Surg. 2013;95(1):220-228.
Anderson HN, Dearani JA, Said SM, et al. Cone reconstruction in children with Ebstein anomaly: the Mayo clinic experience. Congenit Heart Dis. 2014;9(3):266-271.
Malhotra A, Agrawal V, Patel K, et al. Ebstein's anomaly: “The one and a half ventricle heart”. Braz J Cardiovasc Surg. 2018;33:353-361.
Li J, Jiang X, Zhang S, et al. Mid-term outcome of surgical treatment in pediatric patients with Ebstein's anomaly: a single-center cohort study. CHD. 2020;15(5).

Auteurs

Shiraslan Bakhshaliyev (S)

Department of Pediatric Cardiovascular Surgery, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Research Hospital, Istanbul, Turkey.

Zeynep Gülben Kük Özalp (ZGK)

Department of Pediatric Cardiovascular Surgery, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Research Hospital, Istanbul, Turkey.

Mustafa Güneş (M)

Department of Pediatric Cardiovascular Surgery, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Research Hospital, Istanbul, Turkey.

Serhat Bahadır Genç (SB)

Department of Pediatric Cardiovascular Surgery, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Research Hospital, Istanbul, Turkey.

Hacer Kamalı (H)

Department of Pediatric Cardiology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Research Hospital, Istanbul, Turkey.

Fatma Sevinç Şengül (FS)

Department of Pediatric Cardiology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Research Hospital, Istanbul, Turkey.

Servet Ergün (S)

Erzurum Regional Education and Research Hospital, Erzurum, Turkey.

Sertaç Haydin (S)

Department of Pediatric Cardiovascular Surgery, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Research Hospital, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH